Since FOS and JUN are subunits of the transcription factor, AP-1, a critical downstream JNK effector, we determined if the JNK/AP-1 pathway, an important branch of MAPK signaling, contributes to the CDG’s anti-PD effects by influencing apoptosis in PD rat models. This evidence concerns the gene FOS and Parkinson disease.